• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION UNKNOWN IMPLANTABLE NEUROSTIMULATOR; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION UNKNOWN IMPLANTABLE NEUROSTIMULATOR; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS) Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Migration or Expulsion of Device (1395)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/27/2018
Event Type  malfunction  
Manufacturer Narrative
Age/date of birth.This value is the average age of the patients reported in the article as specific patients could not be identified.Sex.This value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Date of event.Please note that this date is based off the date that the article was accepted for publication as the event dates were not provided in the published literature.The main component of the system.Other relevant device(s) are: product id: neu_unknown_lead, serial/lot #: unknown.Product id: neu_unknown_ext, serial/lot #: unknown.Deng, z., pan, y., zhang, c., zhang, j., qiu, x., zhan, s., li, d., sun, b.Subthalamic deep brain stimulation in patients with primary dystonia: a ten-year follow-up study.Parkinsonism relat disord.2018.Doi: 10.1016/j.Parkreldis.2018.05.024.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Summary: background: subthalamic deep brain stimulation (stn-dbs) is a promising intervention for primary dystonia; however, evidence regarding its efficacy is lacking.Thus, a long-term follow-up is indispensable.Objective: this trial was designed to examine the efficacy and consistency of subthalamic deep brain stimulation in patients with primary dystonia over the long term.Method: this was a retrospective study involving 14 patients with primary dystonia who underwent stn-dbs and consented to a follow-up of at least 10 years.The burke-fahn-marsden dystonia rating scale (bfmdrs) and 36-item short-form general health survey were employed, at five time points (pre-operation [baseline], 1 month post-operation, 1 year post-operation, 5 years post-operation, and last follow-up), to assess improvement of dystonic symptoms and changes in quality of life.Outcomes: all patients gained extensive clinical benefits from stn-dbs therapy, without experiencing serious adverse effects.Improvements of 59.0% at 1 month, 85.0% at 1 year, and 90.8% at 5 years after the operation, and up to 91.4% at the last follow-up, were demonstrated by movement evaluation with the bfmdrs.All patients achieved a substantial improvement in quality of life.Conclusion: subthalamic deep brain stimulation is an effective and persisting alternative to pallidal deep brain stimulation, and importantly, it is very safe even with extremely long-term chronic stimulation.Reported events: 1.2 patients with bilateral stn-dbs for primary dystonia experienced electrode displacement.It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN IMPLANTABLE NEUROSTIMULATOR
Type of Device
IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7795173
MDR Text Key117859462
Report Number3007566237-2018-02473
Device Sequence Number1
Product Code MRU
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 08/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/14/2018
Initial Date FDA Received08/17/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age30 YR
-
-